1. Hyporegenerative anemia in anti‐M‐associated hemolytic disease of the fetus
- Author
-
Zhiming He, Yanmin Luo, Yanli Ji, Chunyan Mo, Qun Fang, Si Li, and Yu Gao
- Subjects
Adult ,Male ,Reticulocytosis ,Anemia ,Rho(D) Immune Globulin ,Immunology ,Blood Transfusion, Intrauterine ,Physiology ,030204 cardiovascular system & hematology ,Hematocrit ,Erythroblastosis, Fetal ,Young Adult ,03 medical and health sciences ,Fetus ,0302 clinical medicine ,Reticulocyte ,Isoantibodies ,Pregnancy ,medicine ,Humans ,Immunology and Allergy ,Erythropoiesis ,Reticulocytopenia ,medicine.diagnostic_test ,business.industry ,Infant, Newborn ,Gestational age ,Hematology ,medicine.disease ,Treatment Outcome ,medicine.anatomical_structure ,Immunoglobulin M ,Female ,medicine.symptom ,business ,030215 immunology - Abstract
BACKGROUND The anti-M antibody can lead to hemolytic disease of the fetus and newborn (HDFN) and adverse fetal outcomes, especially in the Asian population. However, fetal erythropoiesis resulting from M alloimmunization needs further investigation. STUDY DESIGN AND METHODS We analyzed erythropoiesis in eight fetuses with M alloimmunization and compared them with the fetuses affected by anti-D. They were matched as pairs according to the gestational age of diagnosis and the hematocrit before treatment. Paired t-tests or paired Wilcoxon rank-sum tests were conducted to compare the difference in the cord blood indexes. Pearson correlation analysis was used to evaluate the correlativity between hematocrit and the reticulocyte percentage in the two groups. RESULTS The fetuses in the MN group had lower reticulocyte count and percentage than those in the RhD group (p
- Published
- 2021
- Full Text
- View/download PDF